Focus on gastroesophageal reflux disease in patients with cystic fibrosis

doi:10.3748/wjg.v26.i41.6322

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 41

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7487)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

440

WORD

151

HTML

4257

Figures (1-1)

375

Tables (1-5)

297

Sum=5520

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

600

Download

1367

Sum=1967

Nov 7, 2020 (publication date) through Dec 27, 2024

Times Cited of This Article

Times Cited (19)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Nov 7, 2020; 26(41): 6322-6334
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6322

Full Size Figure Download Figure

Figure 1 Flow-chart on management of gastroesophageal reflux disease in cystic fibrosis patients. PPI: Proton pump inhibitor.

Citation: Bongiovanni A, Manti S, Parisi GF, Papale M, Mulè E, Rotolo N, Leonardi S. Focus on gastroesophageal reflux disease in patients with cystic fibrosis. World J Gastroenterol 2020; 26(41): 6322-6334
URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6322.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6322